Cargando…

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center

BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishii, Nobuhiro, Tachibana, Motomi, Morimoto, Yoshimasa, Kawada, Satoshi, Miyoshi, Akihito, Sugiyama, Hiroyasu, Nakagawa, Koji, Watanabe, Atsuyuki, Nakamura, Kazufumi, Morita, Hiroshi, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529595/ https://www.ncbi.nlm.nih.gov/pubmed/28765769 http://dx.doi.org/10.1016/j.joa.2017.02.004

Ejemplares similares

Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting
por: Nishii, Nobuhiro, et al.
Publicado: (2017)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
por: Sugiyama, Hirotaro, et al.
Publicado: (2017)

A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring
por: Morimoto, Yoshimasa, et al.
Publicado: (2019)

Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome
por: Ueoka, Akira, et al.
Publicado: (2018)

Prognosis after lead extraction in patients with cardiac implantable electronic devices infection: Comparison of lead‐related infective endocarditis with pocket infection in a Japanese single‐center experience
por: Nishii, Nobuhiro, et al.
Publicado: (2019)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
por: Ferrari, Paola, et al.
Publicado: (2016)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
por: Kondo, Yusuke, et al.
Publicado: (2017)

Open chest epicardial mapping in an asymptomatic patient with Brugada syndrome
por: Watanabe, Atsuyuki, et al.
Publicado: (2019)

Syncope and loss of consciousness after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: Prevalence and characteristics in long-term follow-up
por: Asada, Saori, et al.
Publicado: (2023)

Successful radiofrequency catheter ablation of a premature ventricular contraction triggering ventricular fibrillation in a patient with short QT syndrome
por: Morimoto, Yoshimasa, et al.
Publicado: (2019)

Usefulness of right ventriculography compared with computed tomography for ruling out the possibility of lead perforation before lead extraction
por: Asada, Saori, et al.
Publicado: (2021)

Percutaneous lead extraction for patients with large vegetations using an unusual technique
por: Nishii, Nobuhiro, et al.
Publicado: (2018)

Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block
por: Sousa, Maria João, et al.
Publicado: (2017)

Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
por: Miyamoto, Masakazu, et al.
Publicado: (2023)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
por: Ishibashi, Kohei, et al.
Publicado: (2017)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Significance of Exercise‐Related Ventricular Arrhythmias in Patients With Brugada Syndrome
por: Morita, Hiroshi, et al.
Publicado: (2020)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Significant Delayed Activation on the Right Ventricular Outflow Tract Represents Complete Right Bundle‐Branch Block Pattern in Brugada Syndrome
por: Morimoto, Yoshimasa, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Oversensing caused by trapped air in the header of subcutaneous cardioverter‐defibrillator generator
por: Okada, Takuya, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Successful repositioning of the subcutaneous implantable cardioverter‐defibrillator lead to avoid inappropriate shock
por: Fukunaga, Hiroshi, et al.
Publicado: (2023)

Recording of isolated very delayed potentials on the right ventricular epicardium in a patient with Brugada syndrome
por: Watanabe, Atsuyuki, et al.
Publicado: (2017)

Infection and migration incidence of cardiac implantable electrical devices in Japan: Web‐based survey results
por: Nakajima, Hiroshi, et al.
Publicado: (2020)

Effectiveness of changing conventional implantable cardioverter-defibrillator settings to intrinsic antitachycardia pacing–like settings in the treatment of ventricular tachycardia in patients with cardiac failure
por: Tachibana, Motomi, et al.
Publicado: (2022)

Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
por: Toda, Hironobu, et al.
Publicado: (2019)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Painful detour of subcutaneous implantable cardioverter-defibrillator lead
por: Bisson, Jasmine, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective
por: Nesti, Martina, et al.
Publicado: (2023)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
por: Nakao, Yasuhisa, et al.
Publicado: (2020)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
por: Nishii, Nobuhiro, et al.
Publicado: (2021)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Ultrasound-guided intermuscular pocket creation for a subcutaneous implantable cardioverter-defibrillator
por: Sonoda, Yusuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m98r4b7ajv3isn20o7b8trtqu5